Dataset Information


Doxapram as an additive to propofol sedation for endoscopic retrograde cholangiopancreatography: a placebo-controlled, randomized, double-blinded study.

ABSTRACT: BACKGROUND:Endoscopic retrograde cholangiopancreatography (ERCP) requires moderate to deep sedation, usually with propofol. Adverse effects of propofol sedation are relatively common, such as respiratory and cardiovascular depression. This study was conducted to determine if doxapram, a respiratory stimulant, could be used to reduce the incidence of respiratory depression. METHODS:This is a single-center, prospective randomized double-blind study performed in the endoscopy unit of Helsinki University Central Hospital. 56 patients were randomized in a 1:1 ratio to either receive doxapram as an initial 1 mg/kg bolus and an infusion of 1 mg/kg/h (group DOX) or placebo (group P) during propofol sedation for ERCP. Main outcome measures were apneic episodes and hypoxemia (SpO2?

SUBMITTER: Jokelainen J 

PROVIDER: S-EPMC7644472 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

2020-01-01 | S-EPMC7233161 | BioStudies
2015-01-01 | S-EPMC4581832 | BioStudies
2020-01-01 | S-EPMC7245039 | BioStudies
2015-01-01 | S-EPMC5369549 | BioStudies
2012-01-01 | S-EPMC3434082 | BioStudies
2011-01-01 | S-EPMC3223212 | BioStudies
2020-01-01 | S-EPMC7231242 | BioStudies
2017-01-01 | S-EPMC5561208 | BioStudies
2013-01-01 | S-EPMC3634750 | BioStudies
2016-01-01 | S-EPMC5089092 | BioStudies